New grad roles at Zentalis Pharmaceuticals
Zentalis Pharmaceuticals is a clinical-stage biopharmaceutical company developing differentiated small-molecule therapeutics that target fundamental biological pathways in cancer. Its lead program is azenosertib, an investigational WEE1 inhibitor studied in ovarian cancer and other tumor types.
- Industry
- Biotech & Pharma, Healthcare & Health Tech
- Company size
- 51–200 employees
- Stage
- Public
- Open roles
- 3
No current roles
Check back soon.
Get new Zentalis Pharmaceuticals new grad roles by email
Free account. Get new Zentalis Pharmaceuticals new grad roles by email or push the minute they post.
